Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S144000

Reexamination Certificate

active

06900233

ABSTRACT:
A substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-one, compound of formula 1,wherein R1, R2, R3, R4and R5are as defined herein, pharmaceutical composition comprising the compound and use of the compound for inhibiting pancreatic lipase, or the prophylaxis or treatment of obesity are described.

REFERENCES:
patent: 4150142 (1979-04-01), Boesch
patent: 5093343 (1992-03-01), Bonse et al.
patent: 5236939 (1993-08-01), Bonse
patent: 6369088 (2002-04-01), Schoenafinger et al.
patent: 6596742 (2003-07-01), Petry et al.
patent: 2603877 (1976-08-01), None
patent: 2604110 (1976-08-01), None
patent: 0048040 (1984-08-01), None
patent: 0067471 (1985-11-01), None
patent: 0419918 (1991-04-01), None
patent: WO 01/17981 (2001-03-01), None
patent: WO 01/66531 (2001-09-01), None
1985, CAS:103:178266.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3410174

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.